TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts

Benzinga Logo Benzinga • •By Piero Cingari
Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts

President Trump announced a major pricing deal with Eli Lilly and Novo Nordisk to make weight-loss drugs more affordable, with Medicare and Medicaid coverage starting in April 2026 and monthly out-of-pocket costs reduced to $50-$350.

Insights
HELFY   neutral

Mentioned as expanding into online grocery space, indicating strategic market positioning


LLY   positive

Stock up 20% year-to-date, strong demand for Zepbound, investor optimism about weight-loss and diabetes treatment pipeline